And these data are really quite interesting and impressive that if you don't progress and that your time on [enfortumab ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk ...

The "Bladder Cancer: Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.Bladder cancer (International Classification of Diseases, 10th Revision [ICD-10] codes ...

The promise of incorporating new treatments and predictive biomarkers to select the right patient for the right treatment ...

Most bladder cancers start in the inside lining of the bladder. Muscle-invasive bladder cancer (MIBC) is cancer found in the ...

When John noticed blood in his urine, he consulted his doctor and was quickly referred to a urologist. (John is a composite character, based on the experiences of real-life patients.) John was ...

Citation: Advanced bladder cancer patients with alterations in FGFR3 gene respond well to investigational drug: Clinical trial (2024, October 24) retrieved 15 November 2024 from https ...

Bladder cancer treatment is advancing with new agents, especially for CIS refractory patients ineligible for cystectomy. Understanding patient selection and treatment sequencing is essential due to ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Barcelona, Spain: Patients with advanced bladder cancer that had spread to other parts of the body (metastasised) have responded well in a phase I clinical trial of an investigational drug ...

The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

The hope is that by using TPPs, more new tests will make it to patients and improve diagnosis and cancer care. The project aims to develop a TPP for new bladder and kidney cancer tests to help ...